Drug Development Infrastructure Supporting the Research Community in Medication Repurposing for Substance Use Disorders

National Institutes of Health

See all 357 calls from National Institutes of Health →

Forecast: not open for applications yet. Expected to open February 25, 2027. The funder has announced this call; dates and details can change before it opens.

Should you apply? See the full check →Official call on Grants.gov ↗

Funder
National Institutes of Health
Award amount
Not specified
Deadline
June 1, 2027 Expected
Eligible countries
United States
Where to apply
Grants.gov, opportunity 364252

Last checked against the official source . Confirmed: the date the official call lists. Expected: the funder's estimate before the call opens. Check the funder's page before you apply. Something wrong? Tell us

Summary

Forecasted opportunity (not yet open for applications; expected to be posted around 2027-02-25; estimated application due date 2027-06-01). The National Institute on Drug Abuse (NIDA) seeks to advance its mission by supporting a dynamic and adaptable drug-development infrastructure to accelerate medication repurposing and repositioning for substance use disorders (SUDs). The infrastructure will serve academic and biotech investigators by providing coordinated scientific expertise, shared resources, and tailored support across the drug-development continuum. Capabilities may include in silico discovery, target and assay validation, preclinical and translational development, pharmacology, toxicology, clinical protocol development, patient engagement, Target Product Profile development, Freedom-to-Operate and intellectual property strategy, regulatory guidance, and market-access planning. The infrastructure will also engage the research community through outreach, proposal solicitation, and a structured project-selection process, supporting user-led projects across a broad range of SUD indications. The goal is to help promising repurposed and repositioned therapeutics progress toward clinical development and potential market access. Grant authorities that allow the NIDA to forecast this opportunity are as follows: 42 U.S.C. 241 and 284.

Summary as listed on Grants.gov (opportunity 364252). Always read the full announcement for eligibility, limits and how to apply.

Read the full announcement on Grants.gov →

What National Institutes of Health reviewers look for

  • Importance of the research (significance and innovation), scored 1–9.
  • Rigor and feasibility of the approach, scored 1–9. Preliminary data and alternative strategies carry much of this.
  • Expertise and resources, rated sufficient or not, without a score.
  • Overall impact: the likelihood the project will have a sustained, powerful influence on its field.

Read our guide: what funded applications do →

See how this call matches your research

Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.

Get matched free